Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
7 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Azitra Inc’s names, not what it holds today.
Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 1 in 2024 and 2 in 2023
Applications published
18
3 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals4
Biotechnology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Azitra Inc its own name
named as the applicant on its applications, in US
16 publishedAzitra Inc its own name
US, as the owner printed on each patent
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 23, 2025 | 12,503,691 | Auxotrophic strains of Staphylococcus bacterium | Biotechnology | Azitra Inc |
| Jan 28, 2025 | 12,208,124 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | Pharmaceuticals | Azitra Inc |
| Jul 16, 2024 | 12,036,248 | Therapeutic treatment of skin disease with recombinant commensal skin microorganisms | Pharmaceuticals | Azitra Inc |
| Dec 26, 2023 | 11,850,267 | Methods and compositions for treating skin disease with recombinant microorganisms | Pharmaceuticals | Azitra Inc |
| Oct 3, 2023 | 11,773,154 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | Pharmaceuticals | Azitra Inc |
| Jun 22, 2021 | 11,041,217 | Auxotrophic strains of staphylococcus bacterium | Biotechnology | Azitra Inc |
| Jul 7, 2020 | 10,702,558 | Therapeutic treatment of skin disease with recombinant commensal skin microorganisms | Pharmaceuticals | Azitra Inc |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Mar 20, 2025 | 2025/0090599 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS | Pharmaceuticals | Azitra Inc |
| Feb 6, 2025 | 2025/0043237 | AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIUM | Biotechnology | Azitra Inc |
| Jan 9, 2025 | 2025/0009810 | THERAPEUTIC TREATMENT OF SKIN DISEASE WITH RECOMBINANT COMMENSAL SKIN MICROORGANISMS | Pharmaceuticals | Azitra Inc |
| Jul 18, 2024 | 2024/0238349 | METHODS AND COMPOSITIONS FOR TREATING SKIN DISEASE WITH RECOMBINANT MICROORGANISMS | Pharmaceuticals | Azitra Inc |
| Jul 4, 2024 | 2024/0218049 | COMPOSITIONS AND METHODS FOR TREATMENT OF NETHERTON SYNDROME WITH LEKTI EXPRESSING RECOMBINANT MICROBES | Pharmaceuticals | Azitra Inc |
| May 23, 2024 | 2024/0166990 | METHODS AND COMPOSITIONS FOR INCREASING PROTEIN EXPRESSION IN GENETICALLY ENGINEERED BACTERIA | Pharmaceuticals | Azitra Inc |
| Mar 21, 2024 | 2024/0092869 | EXPRESSION OF THE HUMAN LEKTI GENE FROM THE CHROMOSOME OF STAPHYLOCOCCUS EPIDERMIDIS | Biotechnology | Azitra Inc |
| Apr 14, 2022 | 2022/0112455 | AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIUM | Biotechnology | Azitra Inc |
| Dec 9, 2021 | 2021/0379120 | THERAPEUTIC TREATMENT OF SKIN DISEASE WITH RECOMBINANT COMMENSAL SKIN MICROORGANISMS | Pharmaceuticals | Azitra Inc · patent 12,036,248 granted from it |
| Sep 2, 2021 | 2021/0269791 | AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIUM | Biotechnology | Azitra Inc · patent 12,503,691 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 5 · Biotechnology 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.